Colin Walsh

Colin Walsh

Directeur/Membre du Conseil chez ATTOVIA THERAPEUTICS, INC.
40 ans
Health Technology
Finance
Electronic Technology

Profil

Colin Walsh is currently Director at Ceptur Therapeutics, Inc., Managing Director-Life Sciences Investing at The Goldman Sachs Group, Inc. since 2023, Director at Vicebio Ltd. since 2024, Independent Director at Attovia Therapeutics, Inc. since 2024, and Board Member at Element Science, Inc. since 2019.
Former roles include Independent Director at Elevation Oncology, Inc. from 2019 to 2023, Vice President at NanoDimension, Inc., Partner at Qiming US Ventures Management, LLC from 2020 to 2023, Senior Associate at NanoDimension Management Ltd., Principal at Precision NanoSystems, Inc., and Board Member at Korro Bio, Inc. (United States) from 2020 to 2023.
Education includes a doctorate from the University of California, Berkeley and an undergraduate degree from the University of Massachusetts Amherst.

Postes actifs de Colin Walsh

SociétésPosteDébut
ATTOVIA THERAPEUTICS, INC. Directeur/Membre du Conseil 01/05/2024
THE GOLDMAN SACHS GROUP, INC. Corporate Officer/Principal 01/09/2023
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 01/08/2019
Directeur/Membre du Conseil 01/09/2024

Anciens postes connus de Colin Walsh

SociétésPosteFin
Private Equity Investor 31/10/2023
ELEN ONCO Directeur/Membre du Conseil 21/09/2023
Directeur/Membre du Conseil 01/09/2023
Corporate Officer/Principal -
░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░░ -
Voir l'expérience en détail de Colin Walsh

Formation de Colin Walsh

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

62

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées13

Finance

Electronic Technology

Consumer Services

Finance

Finance

Electronic Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

  1. Bourse
  2. Insiders
  3. Colin Walsh